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Abstract
Purpose Animal studies suggest that gut bacteria
metabolites are involved in regulation of intraocular
pressure or development of glaucoma. However,
clinical data are lacking. Here, we wanted to compare
level of trimethylamine (TMA), an uremic toxin
produced by gut bacteria, along with betaine and
trimethylamine N-oxide (TMAO), a substrate and a
product of its metabolism, in the aqueous humor and in
plasma of patients with glaucoma and their controls.
Methods Twenty patients were selected for cataract
phacoemulsification, and 20 patients selected for
phacotrabeculectomy were enrolled in the study.
Patients were matched with controls on systemic
diseases and estimated glomerular filtration rate.
Blood samples were collected in the preoperative
suite, whereas aqueous humor samples were collected
as the first step of both procedures. Subsequently, level
of betaine, TMA and TMAO was analyzed by means
of chromatography.
Results In the aqueous humor, level of TMA, but not
betaine or TMAO, was significantly higher in the
phacotrabeculectomy group than in the phacoemulsi-
fication group. Plasma level of betaine, TMA and
TMAO was similar between groups. In both groups,
level of betaine and TMA, but not TMAO, was
significantly higher in plasma than in the aqueous
humor.
Conclusion TMA, but not TMAO or betaine level, is
increased in the aqueous humor of patients with
glaucoma. TMA might play a role in pathogenesis of
glaucoma; however, prospective studies are needed to
confirm our findings.
Keywords TMA  TMAO  Intraocular pressure 
Betaine
Introduction
The most recent studies prove that bacterial metabo-
lites are involved in pathophysiology of many diseases
[1]. Their role in multiple sclerosis, hypertension,
heart failure or cancer has been highlighted [2].
Furthermore, recent evidence implies that gut
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bacterial metabolites, including short-chain fatty acids
(SCFA), hydrogen sulfide and trimethylamine N-ox-
ide (TMAO), play an important role in regulation of
intraocular pressure (IOP) [3–5].
In vitro experiments suggest that TMAO, a product
of betaine, choline and carnitine metabolism, stabi-
lizes mutant myocilin and prevents degradation of
trabecular meshwork in the juvenile, hereditary glau-
coma [4]. Observations regarding TMAO were linked
to its chaperonic activity [4]. Notably, TMAO protects
cardiomyocytes from increased load in the setting of
hypertension or heart failure in rats and acts as a buffer
against increased osmotic and hydrostatic pressure in
the deep-sea animals [6–8]. In contrast, trimethy-
lamine (TMA), a substrate for TMAO synthesis, exerts
cytotoxic effect on vascular smooth muscles and
cardiomyocytes [9, 10].
Interestingly, role of TMA and TMAO in primary
open-angle glaucoma (POAG) has not been thor-
oughly investigated in clinical studies so far. It is
possible that TMAO acting as a chaperone might
protect proteins in the outflow pathways as well as in
the optic nerve fibers from pressure-related degener-
ation [11]. Contrarily, TMA might negatively affect
optic fibers and smooth muscle cells in the trabecular
meshwork [12]. These negative effects of TMA might
be primarily related to its effects on lactate dehydro-
genase, an enzyme involved in protection against
hypoxic stress—one of causative factors for develop-
ment and progression of glaucoma [12–14].
Furthermore, although various cardiovascular dis-
eases, ischemic heart disease or hypertension, are
linked to development of glaucoma, mechanistic
relationship between these seemingly distinct entities
is far from clear. We believe that TMA and TMAO
might constitute a common humoral background
which affects not only cardiovascular system, but also
has a direct or indirect effect on the structure of the
optic nerve. Firstly, TMA and TMAO are involved in
blood pressure (BP) homeostasis [15–17]. Notably,
dysregulation of BP is considered a risk factor for both
cardiovascular mortality and glaucoma [18, 19].
Secondly, TMAO was shown to accelerate develop-
ment of atherosclerosis which is considered a risk
factor for glaucoma [20–22].
Here, we evaluated the levels of TMA, TMAO and
betaine, a TMA precursor, in the aqueous humor and
in the blood of patients with increased and normal
IOP.
Materials and methods
This cross-sectional study was approved by the
Bioethical Committee at the Medical University of
Warsaw and adhered to the Declaration of Helsinki.
All patients were enrolled at the Department of
Ophthalmology at the Medical University of Warsaw,
a tertiary eye care center in Poland.
Considering the preliminary character of the study
and lack of sufficient data to calculate power of the
study number of participants was arbitrarily set at 20 in
both groups.
Inclusion criteria
The first group consisted of patients undergoing
routine cataract surgery. Patients with advanced
primary open-angle glaucoma, who were selected for
combined procedure of phacoemulsification and tra-
beculectomy, were included in the second group.
Considering that level of TMA was shown to be
inversely proportional to estimated glomerular filtra-
tion rate (eGFR) [10], whereas level of TMAO
correlates with cardiovascular mortality; we decided
to match patients on eGFR as well as diseases related
to cardiovascular mortality, i.e., diabetes, hyperten-
sion and ischemic heart disease. To calculate eGFR,
we utilized Modification of Diet in Renal Disease
(MDRD) study equation.
Both groups underwent routine slit-lamp examina-
tion, including IOP measurement and optic nerve disc
assessment. Patients were selected for phacotra-
beculectomy procedure based on increased cup-to-
disc ratio, elevated IOP and other morphological or
functional features of glaucomatous neuropathy,
including visual field or optical coherence tomography
examination.
Exclusion criteria
Conditions which might impair blood–aqueous humor
barrier were set as exclusion criteria, including uveitic
or traumatic cataract and proliferative diabetic
retinopathy. Furthermore, patients with known gas-
trointestinal disorders which increase permeability of
gut–blood barrier and patients who underwent treat-
ment with antibiotics 3 months prior to the study were
excluded as well. Additionally, patients treated for
glaucoma were not included in the control group.
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Collection of aqueous humor sample
Aqueous humor was collected at the beginning of the
procedure. Following a clear corneal, 1 mm paracen-
tesis 30G cannula was introduced to the anterior
chamber of the eye and 100 ll of the aqueous humor
was aspirated. In order to avoid contamination of the
aqueous humor with blood, care was taken not to
injure limbal vessels. Following collection of fluid,
both phacoemulsification and phacotrabeculectomy
procedures were performed as usual. Aqueous humor
was stored at – 20 C before analysis.
Collection of peripheral blood sample
Sample of venous blood was collected to a vial
containing EDTA. Collection was performed in the
preoperative suite before infusion of sedating drugs;
2 ml of blood was centrifuged at 5000/min for 10 min,
and serum was aspirated and transferred to an empty
vial which was subsequently stored at – 20 C before
analysis.
Betaine, TMA and TMAO concentration
evaluation (chromatography)
Chemicals The following chemicals were used: LC–
MS grade—acetonitrile, HPLC gradient grade acetone
(POCh), 25% ammonium hydroxide and formic acid
(J.T. Baker). Ultra-pure water was obtained from
water purification system (Milli-Q, Millipore). TMA,
TMAO and betaine hydrochloride were purchased
from Sigma-Aldrich. All stock solutions were pre-
pared in methanol.
Sample preparation It was performed as follows:
10 ll of sample was mixed with 100 ll of acetone
containing internal standards. After the mixture was
vortexed and centrifuged. A 7 ll of aliquot was
injected into apparatus.
Analytes They were quantified at the Institute of
Biochemistry and Biophysics using liquid chromatog-
raphy–tandem mass spectrometry method. The instru-
mentation consisted of a Waters Acquity Ultra-
Performance Liquid Chromatograph coupled with
Waters TQ-S triple quadrupole mass spectrometer.
Chromatographic separation was performed using a
Waters HILIC column (1.7 lm, 2.1 mm 9 50 mm)
thermostated at 70 C. Mobile phase A was Milli-Q
water with addition of 1 ml of 25% NH4OH per
1000 ml of water, and mobile phase B was 1 ml of
formic acid in 1000 ml of acetonitrile. The flow rate of
mobile phase was set at 0.5 ml/min. The total time of
separation was 1.7 min. The mass spectrometer oper-
ated in multiple-reaction monitoring (MRM) negative
electrospray ionization (ESI-) mode for indoxyl
sulfate and in multiple-reaction monitoring (MRM)
positive electrospray ionization (ESI?) mode for
other analytes. The calibration curve ranges were
0.02–20 lg/ml for TMAO, 0.1–120 lg/ml for TMA,
0.1–50 lg/ml for indoxyl sulfate and 0.02–10 lg/ml.
Mean R2 coefficients of a calibration curves from six
calibrators were not lower than 0.99.
Statistical analysis
Data were analyzed for normal distribution with
Kolmogorov–Smirnov test. Differences between
groups were tested for statistical significance with
unpaired Student t test. Contingency tables were
analyzed with Cochran’s Q test. Level of statistical
significance was set at 0.05. All analyses were
performed with Graphpad (Prism, USA) and Excel
(Microsoft, USA).
Results
Characteristics of the studied population are included
in Table 1. There was a statistically significant
difference in IOP between phacoemulsification and
phacotrabeculectomy groups (P\ 0.001). There were
no statistically significant differences in age, eGFR,
number of patients with diabetes, hypertension or
ischemic heart disease between groups.
Plasma and aqueous humor levels of TMA, betaine
and TMAO
Plasma level of TMA and betaine was significantly
higher than aqueous humor level of TMA and betaine
in both groups (phacotrabeculectomy betaine
P\ 0.001; TMA P = 0.001) (phacoemulsification
betaine P\ 0.001; TMA P\ 0.001). There was no
difference between aqueous humor and plasma level
of TMAO (Fig. 1a, b).
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Phacoemulsification versus phacotrabeculectomy
Aqueous humor level of TMA, but not betaine or
TMAO, was significantly higher (P\ 0.001) in
phacotrabeculectomy group than in phacoemulsifica-
tion group (Fig. 1a). There were no significant differ-
ences between plasma level of TMA, betaine and
Table 1 Characteristics of
the group
Results are expressed as an
absolute number or a
mean ± standard error of
the mean (SEM)
LOCS III—The lens
opacities classification
system
Phacoemulsification Phacotrabeculectomy P
Number 20 20 P[ 0.05
Age 73.7 ± 1.8 72.1 ± 1.9 P[ 0.05
IOP (mmHg) 13.3 ± 0.8 21.5 ± 1.6 P\ 0.05
Creatinine (mg/ml) 0.82 ± 0.04 0.84 ± 0.04 P\ 0.05
eGFR (ml/min/1.73 m2) 87 ± 6 90 ± 5 P[ 0.05
Cup-to-disc ratio 0.3 ± 0.1 0.8 ± 0.2 P\ 0.05
Number of anti-glaucoma drugs 0 3 ± 0.2 P\ 0.05
Mean deviation (visual field) 0.2 ± 0.5 6.2 ± 1.2 P\ 0.05
LOCS III nuclear score 3 ± 0.3 3.2 ± 0.35 P[ 0.05
Diseases related to cardiovascular mortality
Hypertension 16 14 P[ 0.05
Ischemic heart disease 5 3 P[ 0.05
Diabetes 4 5 P[ 0.05
Classes of anti-glaucoma medication
Prostaglandins 0 16 P\ 0.05
Beta blockers 0 14 P\ 0.05
Alpha-2 agonists 0 15 P\ 0.05
Anhydrase inhibitors 0 16 P\ 0.05
Fig. 1 a Aqueous humor
level of trimethylamine
(TMA), trimethylamine
N-oxide (TMAO) and
betaine. b Plasma level of
trimethylamine (TMA),
trimethylamine N-oxide
(TMAO) and betaine.
*p\ 0.05
phacoemulsification TMA
versus phacotrabeculectomy
TMA. $p\ 0.05 plasma
TMA versus aqueous humor
TMA; plasma betaine versus
aqueous humor betaine
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TMAO in phacotrabeculectomy and phacoemulsifica-
tion groups (Fig. 1b).
Discussion
Here, we have found that the aqueous humor contains
TMA, a gut bacteria metabolite, as well as a substrate
and a product of its metabolic pathway, i.e., betaine
and TMAO, respectively. Furthermore, we have
shown that level of TMA in the aqueous humor of
patients with advanced open-angle glaucoma is sig-
nificantly higher than in phacoemulsification control
group.
Betaine, L-carnitine and choline are abundant in red
meat and in deep-sea animals [23, 24]. They are
metabolized by gut bacteria to TMA, which is in turn
oxygenated to TMAO in the liver [25]. Additionally,
saltwater fish constitute an important direct dietary
source of TMAO [26].
The landmark study which linked an increased level
of TMAO to cardiovascular mortality triggered inter-
est in hypothesis that products of L-carnitine and
betaine metabolism, which involves gut bacteria, play
a pivotal role in maintenance of homeostasis [27, 28].
Basic and clinical research which followed proved that
TMAO prolongs effects of angiotensin II and plays a
role in carcinogenesis or development of diabetes [26].
However, growing body of research shows that it is
not TMAO, which is a product of liver oxygenation of
TMA, but rather TMA itself is toxic and might be
responsible for decreased viability of smooth muscles
or cardiomyocytes and may directly lead to dysregu-
lation of homeostasis [10].
To the best of our knowledge, no previous clinical
study investigated the presence of gut bacteria
metabolites in the aqueous humor of patients with
cataract and patients with cataract and glaucoma.
Here, we have found that betaine, TMA and TMAO
are present in the aqueous humor of cataract patients
and patients with both cataract and glaucoma. Inter-
estingly, although level of TMAO in the aqueous
humor and in the plasma is similar, concentration of
TMA and betaine in the eye is twofold lower than in
the plasma. Considering that the exclusive locations of
TMAO and TMA synthesis are the liver and the gut,
respectively [29], our findings suggest that TMAO
diffuses freely from blood to the aqueous humor and
does not undergo metabolism in the eye. In contrast,
distribution of TMA and betaine to the eye might be
restricted by specific transporters, active removal or
metabolism.
Furthermore, we have found that level of TMA in
the aqueous humor of glaucoma patients is signifi-
cantly higher than in cataract patients. Considering
that TMA has been shown to impair smooth muscle
function [10], we hypothesize that TMA might
negatively affect smooth muscle cells in the trabecular
meshwork and decrease filtration. What is more, TMA
was found to accelerate degeneration of lactate
dehydrogenase (LDH) [10]. It is well established that
mechanisms involved in response to hypoxia, includ-
ing LDH, are impaired in glaucomatous eyes [13, 14].
We hypothesize that TMAmight further interfere with
defense mechanisms against hypoxic stress and
accelerate development or progression of glaucoma.
Furthermore, large cross-sectional studies showed
positive correlation between chronic kidney disease
and incidence of open-angle glaucoma [30, 31].
Notably, given that plasma level of TMA is inversely
correlated with eGFR, TMA might constitute a
plausible mechanistic link between chronic kidney
disease and glaucoma [10].
Limitations of our study should be underlined.
Firstly, considering that patients selected for phaco-
trabeculectomy procedure were under influence of
anti-glaucoma medication, we cannot rule out effects
of these drugs on level of betaine, TMA and TMAO,
particularly in the aqueous humor. Secondly, we
cannot rule out influence of other factors, including
diet or baseline IOP in the phacotrabeculectomy
group. Finally, prospective and randomized trials are
needed to fully elucidate role of gut bacteria metabo-
lites in the development and progression of glaucoma.
In conclusion, TMA, but not TMAO or betaine
level is increased in the aqueous humor of patients
with glaucoma. TMA might play a role in pathogen-
esis of glaucoma, however, prospective studies are
needed to confirm our findings.
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